Is CYP2C19 useful for Wechseljahre?

CYP2C19 encodes a drug-metabolizing enzyme of the cytochrome P450 family, involved in breaking down medications such as proton pump inhibitors, antidepressants, and clopidogrel. For menopause (Wechseljahre) itself, CYP2C19 has no direct role, as it does not regulate hormones or influence typical menopausal symptoms like hot flashes or mood swings. However, knowledge of CYP2C19 variants may become relevant when menopausal women take drugs metabolized by this enzyme, such as certain SSRIs or hormone replacement therapy. Variants can affect drug efficacy and side effect risk. That said, the provided context contains no evidence linking CYP2C19 testing to menopause management. The evidence is therefore rated as unclear. Consumers should not rely on genetic tests alone for menopause-related decisions; clinical guidance is essential.